L01FX Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
45 active ingredients 45 principios activos 45 个活性成分 45 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
- 佐妥昔单抗
L01FXactiveCN - 依沃西单抗
L01FXactiveCN - Amivantamab
L01FX18activeUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - 埃纳妥单抗
L01FXactiveCN - 塔奎妥单抗
L01FXactiveCN - 戈沙妥珠单抗
L01FXactiveCN - 特立妥单抗
L01FXactiveCN - 索米妥昔单抗
L01FXactiveCN - 维恩妥尤单抗
L01FXactiveCN - 维泊妥珠单抗
L01FXactiveCN - 芦康沙妥珠单抗
L01FXactiveCN - 莫妥珠单抗
L01FXactiveCN - 莫格利珠单抗
L01FXactiveCN - 那西妥单抗
L01FXactiveCN - Belantamab Mafodotin
L01FX15withdrawnESactiveUS·GB·CA·ES·TW·EUunknownAU·HK·EU - Blinatumomab
L01FX07activeGB·CA·AU·SG·ES·TW·EUunknownAU·HK - Brentuximab Vedotin
L01FX05discontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Catumaxomab
L01FX03withdrawnEUdiscontinuedCA·ESactiveGB·EU - Datopotamab Deruxtecan
L01FX35discontinuedESactiveUS·SG·MX·TW·EUunknownAU·HK - Dinutuximab
L01FX06withdrawnEUactiveUS·CA - Dinutuximab Beta
L01FX06activeGB·ES·TW·EUunknownAU·HK - Elotuzumab
L01FX08discontinuedCAactiveUS·GB·AU·ES·TW·EUunknownAU·HK - Elranatamab
L01FX32activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Enfortumab Vedotin
L01FX13discontinuedESactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Epcoritamab
L01FX27activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Gemtuzumab Ozogamicin
L01FX02activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK·EU - Glofitamab
L01FX28activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Ipilimumab
L01FX04discontinuedESactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Linvoseltamab
L01FXdiscontinuedESactiveUS·EU - Loncastuximab Tesirine
L01FX22discontinuedESactiveUS·GB·CA·SG·TW·EUunknownAU·HK - Mirvetuximab Soravtansine
L01FX26activeUS·GB·CA·SG·ES·TW·EUunknownAU - Mogamulizumab
L01FX09activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU - Mosunetuzumab
L01FX25discontinuedESactiveUS·GB·CA·SG·ES·TW·EUunknownHK - Naxitamab
L01FX21activeUSunknownHK - Odronextamab
L01FX34discontinuedESactiveEU - Olaratumab
L01FX10withdrawnEUdiscontinuedCAactiveGB - Polatuzumab Vedotin
L01FX14discontinuedESactiveUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Sacituzumab Govitecan
L01FX17activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Tafasitamab
L01FX12activeUS·GB·CA·AU·ES·TW·EUunknownAU·HK - Talquetamab
L01FX29activeUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Tarlatamab
L01FX33discontinuedESactiveGB·CA·SG·TW·EUunknownAU·HK - Teclistamab
L01FX24activeUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Tisotumab Vedotin
L01FX23discontinuedESactiveUS·GB·EUunknownHK - Tremelimumab
L01FX20withdrawnEUactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Zolbetuximab
L01FX31discontinuedESactiveUS·GB·CA·SG·TW·EUunknownAU·HK
By dosage form, across markets
An ATC class only groups medicines by similar pharmacology/chemistry — it does not mean they are interchangeable. A different ingredient, dosage form, release mechanism or strength is not interchangeable.
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.